Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT03622892

Non-invasive Prenatal Diagnosis of Monogenic Disorders by Linked-reads Technology

Sponsor: University Hospital, Brest

View on ClinicalTrials.gov

Summary

Description of the presence of cell-free fetal DNA in maternal plasma allowed the possibility of non-invasive prenatal diagnosis. Whereas detection of paternally-inherited alleles is straightforward and being quickly implemented in routine, detection of maternally-inherited alleles remains challenging. To date, the main approach that is being developped, called Relative Haplotype Dosage Analysis, relies on the identification of an allelic imbalance between the mother's wild-type and mutant alleles, relative to the fetal's contribution. This approach therefore requires the study of a propositus to identify the morbid haplotype, which is not always possible in the context of an ongoing pregnancy. In this study, we aim to evaluate the contribution of new technologies, such as linked-read Sequencing, to allow direct identification of parental haplotype in the context of non-invasive prenatal diagnosis.

Official title: Universal Haplotype-Based Non Invasive Prenatal Diagnosis by Linked-Read Sequencing (10XGenomics™ Technology)

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

OBSERVATIONAL

Enrollment

28

Start Date

2018-10-18

Completion Date

2022-09-05

Last Updated

2026-06-26

Healthy Volunteers

Yes

Conditions

Locations (6)

CHRU de Brest

Brest, France

CHRU de Dijon

Dijon, France

CHU de Nantes

Nantes, France

CHU de Rennes

Rennes, France

CHU de Rouen

Rouen, France

CH Saint Brieuc

Saint-Brieuc, France